In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma

NCT02740049 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: VR588

Sponsor

Imperial College London

Collaborators

[object Object]